Targeted Interference with Signal Transduction Events - Recent Results in Cancer Research 172 (Hardback)B. Groner (editor)
- Not available
This book does nothing less than lay out the state of development of tomorrow's cancer drugs, directed against growth factors, growth factor receptors and intracellular signaling molecules with kinase activities. The sequencing of the human genome and insights into signaling pathways have contributed to the understanding of cancer etiology and the development of new, improved cancer drugs such as Herceptin and Glivec. The deregulation of pathways due to mutated cancer genes provides the conceptual basis for future progress. Will it be possible to derive more efficient cancer drugs?
Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Number of pages: 188
Dimensions: 244 x 170 mm
Edition: 2007 ed.
You may also be interested in...
Please sign in to write a review